Bsense Bio Therapeutics Overview
Bsense Bio Therapeutics is developing small molecules for the treatment of neuropathic pain. The company is pioneering a novel approach that targets multiple pain-related mechanisms using a single compound to achieve greater efficacy and safety. Bsense Bios approach is based on the targeting of two cation channels, a ligand-gated and a voltage-gated potassium channel (TRPV1 and Kv7.2/3, respectively), which are co-localized on sensory nociceptive neurons and are widely recognized as prominent players in pain signaling. Bsense is currently assessing in depth the specificity and selectivity in vitro of three lead compounds with the purpose of progressing into in vivo safety and efficacy studies. In addition, the company is performing structural activity relation studies to assess whether they can improve the compounds characteristics to achieve a backup compound series. The company is financed by Takeda Ventures Inc, OrbiMed Israel Partners, Johnson & Johnson Innovation (JJDC), and the Israel Innovation Authority (IIA). Bsense Bio Therapeutics was founded at the FutuRx biotech incubator.
Cumulative Funding Raised Over Time ($)
Latest News
No news articles.
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $2.7M |
| Last funding | $2.7M |
| Stage | Seed |
| Rounds | 1 |
| Investors | 5 |
Team Members
2
Employees: 1-10
Web & Social Links
| Website | www.futurx.co.il/portfolio/bsense-bio-therapeutics |
Locations
Ilan Ramon 2, Ness Ziona, Israel
Photos & Videos
No files yet
Bsense Bio Therapeutics Business
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentTarget Customer
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticalsCore Technology
BiologicalsMoleculesTags (7)
pharmaceuticalsneurologybiotechnologydiabetestargeted-therapytreatmentspharma-companiesGeographic Markets
GlobalBsense Bio Therapeutics Financials
Cumulative Funding Raised Over Time ($)
Private Equity Funding
Bsense Bio Therapeutics Lifecycle
Cumulative Funding Raised Over Time
All Events
Bsense Bio Therapeutics News
0 articlesNo news articles.
Bsense Bio Therapeutics Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 6 |
| Team members | 2 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 9 classification IDs that could be used for matching.
Bsense Bio Therapeutics Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 95/100 |
| Missing | video or image, news, markets, external profiles |
| BI Verification | Natalia Golczar |
| Registrar ID | 515817088 |
| Phone | +97289553142 |
| Creator | Yotam Maman |
| Creator email | yotamm1988@gmail.com |
| Last updater | Orli Wollner |
| Updater email | orlushka@gmail.com |
| Last update | 2020-10-10T00:00:00.000Z |
| Created | 2018-10-07T00:00:00.000Z |
| Claimed | Yes |